Novel inhalable gene therapy trialed for people with cystic fibrosis

Updated on: March 29,2025 0

Novel inhalable gene therapy trialed for people with cystic fibrosis

Updated on:March 29,2025 0

Biobanking on health: Sharing biological samples and data to build a healthier future

Updated on: March 29,2025 0

Biobanking on health: Sharing biological samples and data to build a healthier future

Updated on:March 29,2025 0

Scientists uncover method to halt key driver of prostate and other cancers

Updated on: March 29,2025 0

Scientists uncover method to halt key driver of prostate and other cancers

Updated on:March 29,2025 0

Digging into a decades-old hepatitis B mystery suggests a new potential treatment

Updated on: March 29,2025 0

Digging into a decades-old hepatitis B mystery suggests a new potential treatment

Updated on:March 29,2025 0

Stealth virus: How Zika builds tunnels to covertly infect cells of the placenta

Updated on: March 29,2025 0

Stealth virus: How Zika builds tunnels to covertly infect cells of the placenta

Updated on:March 29,2025 0

De-escalating DAPT to ticagrelor monotherapy cuts bleeding risk in acute coronary syndrome

Updated on: March 28,2025 0

De-escalating DAPT to ticagrelor monotherapy cuts bleeding risk in acute coronary syndrome

Updated on:March 28,2025 0

Study reveals activity of navtemadlin in glioblastoma, points to possible treatment improvements

Updated on: March 28,2025 0

Study reveals activity of navtemadlin in glioblastoma, points to possible treatment improvements

Updated on:March 28,2025 0

Global study finds new medication for sinus thrombosis is just as safe but more patient-friendly

Updated on: March 28,2025 0

Global study finds new medication for sinus thrombosis is just as safe but more patient-friendly

Updated on:March 28,2025 0

Study yields unexpected results from empagliflozin after heart attack

Updated on: March 28,2025 0

Study yields unexpected results from empagliflozin after heart attack

Updated on:March 28,2025 0

Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds

Updated on: March 28,2025 0

Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds

Updated on:March 28,2025 0